Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome
Trial details
- Registry ID
- NCT02352896
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Vincerinone, Vatiquinone
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh SyndromeNCT02352896 | PTC Therapeutics | Phase 2 | Completed | 2023-10-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |